Zandstra Named Director of Medicine by Design; New Funding Announced

Jan 14, 2016

U of T President Meric Gertler greets Prime Minister Justin Trudeau as Prof. Peter Zandstra and Michael May look on.U of T President Meric Gertler greets Prime Minister Justin Trudeau as Prof. Peter Zandstra and Michael May look on. Regenerative medicine at the University of Toronto took a big step forward on January 13 thanks to a series of announcements, including the appointment of Professor Peter Zandstra as the inaugural director of Medicine by Design. Canadian Prime Minister Justin Trudeau was on hand for the announcements, where he heralded regenerative medicine as the way of the future for Canadian health cares.

Trudeau announced at the MaRS Discovery District that the federal government will give a $20 million grant to the Centre for Commercialization of Regenerative Medicine (CCRM) to establish and operate a new Centre for Advanced Therapeutic Cell Technologies.

“Regenerative medicine is the future,” Trudeau said. “Not only is it the future, it's a branch of medicine that Canada and the province of Ontario are actually quite good at.”

At the same time, Vivek Goel, vice-president, research and innovation at U of T, announced Zandstra’s appointment. CCRM is the commercial arm of Medicine by Design, a program created last year through a $114 million grant from the federal government. Zandstra is also the chief scientific officer for CCRM.

Trudeau toured two CCRM labs at the Banting Institute with Zandstra, U of T President Meric Gertler and Michael May, the president and CEO of CCRM, along with Navdeep Bains, Minister of Innovation, Science and Economic Development, and Chrystia Freeland, Minister of International Trade and MP for University-Rosedale. The group then moved across College St. to MaRS, which will become the new home of CCRM later this year.

GE Healthcare is also committing $20 million to the new centre. Kieran Murphy, CEO of GE Healthcare’s life sciences business, said in a news release that “it is increasingly clear that cell therapies and regenerative medicine will transform health care globally, but successful industrialization is now crucial to widespread adoption.

“This new centre,” Murphy said, “will enable us to work with cell therapy companies to push beyond existing technical limits and problem-solve. Toronto’s concentrated and collaborative clinical infrastructure, combined with the strong guidance of the internationally-renowned CCRM, make it an ideal location for the centre.”

It is expected that the global market for cell-based therapies will surpass $20 billion U.S. by 2025. The main targets for cell-based therapies are cancer, heart disease, neurodegenerative diseases, musculoskeletal disorder and autoimmune diseases.

Trudeau noted that the new centre will be the first in the world to use a collaborative approach between research institutions and industry to solve cell therapy manufacturing challenges. He said the centre will create jobs, strengthen Canada’s knowledge economy and position Ontario as a global hub for the cell therapy industry.

The Prime Minister said he has “great respect” for scientists involved in stem cell research, not only because of what they are doing for the health of Canadians but how “they are pushing the frontiers of science and innovation.” 

The bottom line, he said, is that “we must do more to prevent diseases” and the collaboration between public institutions like U of T and its partner hospitals, the private sector and government is crucial in “accelerating the development” of stem cell manufacturing technologies.

Zandstra is a professor in the U of T Institute of Biomaterials & Biomedical Engineering, holds the Canada Research Chair in Stem Cell Bioengineering, and is a principal investigator at the Donnelly Centre for Cellular and Biomolecular Research. He told U of T News he is thrilled to be the executive director of Medicine by Design. “But the big news today is the funding of the new centre. We are very thankful” for the government’s commitment. 

The mandate of Medicine by Design is to undertake transformative research and clinical translation in regenerative medicine, enhance capability in synthetic biology and computational biology and foster translation, commercialization and clinical impacts.

It was formed as a result of the University of Toronto’s success in the Canada First Research Excellence Fund (CFREF). The $114 million will be spread over seven years, and will allow U of T and its partners to build on years of support for U of T’s regenerative medicine researchers from federal granting councils, the Canada Foundation for Innovation and support from the Canada Research Chairs and Canada Excellence Research Chairs programs. 

Zandstra will lead and provide over-all scientific direction to the Medicine by Design initiative. May, CEO of CCRM, said the new centre is a “significant milestone” in the fight to find cures for diseases and to create companies that will bring those cures to the marketplace.

And he reminded everyone that the incredible advances in stem cell therapy and its application “trace back to the discovery of stem cells 65 years ago” by U of T scientists James Till and Ernest McCulloch


Temerty Medicine
RT : Have you listened to Ep 82 Making Strides: Amputation & Prosthetics yet? 🎧 Aristotle Domingo () shared his…
Temerty Medicine
RT : To avoid a 'twindemic' health officials are telling Canadians to following guidelines for the pandemic, and to get…
Temerty Medicine
“If we can't learn from it then it has little to no scientific value.” Scientists are challenging their colleagues…

Researchers are mobilizing against the novel SARS-CoV-2 coronavirus and COVID-19.

Make a gift and support their important work.
Sep 23 – Nov 11
Safer Opioid Prescribing
Course | 7:00am–9:00pm
Oct 5 – May 6
Academic Health Leadership Training – Now Accepting Applications 2020-2021 Cohort
Course | 8:00am–5:00pm
Oct 13 – Jun 8
Certificate Program in CPD Foundations
Course | 12:00pm–1:30pm
Oct 21 Creating AODA-Compliant Documents for the Web
Webinar | 10:30am–12:00pm
Oct 22 Medicine and the Machine: The Artificial Intelligence Health Revolution
Temerty Medicine Talk | 12:30pm–1:15pm
Oct 23 U of T Oncology Continuing Education Zoom Rounds - October 2020
Grand Rounds | 8:00am–9:00am
24 – 26
Organ Imaging Review
Symposium | 7:15am–5:15pm